Stocks and InvestingStocks and Investing
Thu, August 18, 2022
Wed, August 17, 2022
Tue, August 16, 2022
Mon, August 15, 2022

Swayampakula Ramakanth Maintained (VOR) at Strong Buy with Decreased Target to $20 on, Aug 15th, 2022


Published on 2024-10-27 22:40:15 - WOPRAI, Swayampakula Ramakanth
  Print publication without navigation


Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Vor Biopharma Inc." (VOR) at Strong Buy with Decreased Target from $26 to $20 on, Aug 15th, 2022.

Swayampakula has made no other calls on VOR in the last 4 months.



There are 3 other peers that have a rating on VOR. Out of the 3 peers that are also analyzing VOR, 1 agrees with Swayampakula's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrea Tan of "Goldman Sachs" Maintained at Hold with Decreased Target to $4 on, Tuesday, May 24th, 2022


These are the ratings of the 2 analyists that currently disagree with Swayampakula


  • David Nierengarten of "Wedbush" Initiated at Buy and Held Target at $18 on, Tuesday, July 26th, 2022
  • Silvan Tuerkcan of "JMP Securities" Maintained at Buy with Decreased Target to $15 on, Friday, May 13th, 2022